These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy. Asif A; Epstein DL; Epstein M J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304 [TBL] [Abstract][Full Text] [Related]
9. Use of high-dose gadolinium as contrast media to avoid radiocontrast media-induced nephropathy. Ruangkanchanasetr P; Rojanamethin S; Ruamthanthong A; Chaiprasert A; Supaporn T J Ren Care; 2009 Mar; 35(1):11-5. PubMed ID: 19200272 [TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of contrast-induced nephropathy. Al-Ghonaim M; Pannu N Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099 [TBL] [Abstract][Full Text] [Related]
11. [Contrast-induced acute renal failure]. Giannattasio M G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365 [TBL] [Abstract][Full Text] [Related]
12. [Nephropathy caused by radiocontrast media]. Kolarz M; Sułowicz W Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535 [TBL] [Abstract][Full Text] [Related]
13. Radiocontrast nephropathy: the dye is not cast. Lepor NE Rev Cardiovasc Med; 2000; 1(1):43-54. PubMed ID: 12457151 [TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy. McCullough PA; Soman SS Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162 [TBL] [Abstract][Full Text] [Related]
17. Toxicity of contrast media: an update. ten Dam MA; Wetzels JF Neth J Med; 2008 Nov; 66(10):416-22. PubMed ID: 19011267 [TBL] [Abstract][Full Text] [Related]
18. [Physiopathology, clinical aspects and prevention of renal insufficiency caused by contrast media]. Savazzi G; Cusmano F; Allegri L; Garini G Recenti Prog Med; 1997 Mar; 88(3):109-14. PubMed ID: 9173467 [TBL] [Abstract][Full Text] [Related]
19. [Review of the radiocontrast nephropathy risk profiles and risk stratification]. Toprak O; Cirit M; Bayata S; Yeşil M Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363 [TBL] [Abstract][Full Text] [Related]
20. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]